228 related articles for article (PubMed ID: 30905597)
1. Dual knockdown of Galectin-8 and its glycosylated ligand, the activated leukocyte cell adhesion molecule (ALCAM/CD166), synergistically delays in vivo breast cancer growth.
Ferragut F; Cagnoni AJ; Colombo LL; Sánchez Terrero C; Wolfenstein-Todel C; Troncoso MF; Vanzulli SI; Rabinovich GA; Mariño KV; Elola MT
Biochim Biophys Acta Mol Cell Res; 2019 Aug; 1866(8):1338-1352. PubMed ID: 30905597
[TBL] [Abstract][Full Text] [Related]
2. Glycosylation-dependent binding of galectin-8 to activated leukocyte cell adhesion molecule (ALCAM/CD166) promotes its surface segregation on breast cancer cells.
Fernández MM; Ferragut F; Cárdenas Delgado VM; Bracalente C; Bravo AI; Cagnoni AJ; Nuñez M; Morosi LG; Quinta HR; Espelt MV; Troncoso MF; Wolfenstein-Todel C; Mariño KV; Malchiodi EL; Rabinovich GA; Elola MT
Biochim Biophys Acta; 2016 Oct; 1860(10):2255-68. PubMed ID: 27130882
[TBL] [Abstract][Full Text] [Related]
3. Galectin-8: a matricellular lectin with key roles in angiogenesis.
Troncoso MF; Ferragut F; Bacigalupo ML; Cárdenas Delgado VM; Nugnes LG; Gentilini L; Laderach D; Wolfenstein-Todel C; Compagno D; Rabinovich GA; Elola MT
Glycobiology; 2014 Oct; 24(10):907-14. PubMed ID: 24939370
[TBL] [Abstract][Full Text] [Related]
4. Biologic role of activated leukocyte cell adhesion molecule overexpression in breast cancer cell lines and clinical tumor tissue.
Hein S; Müller V; Köhler N; Wikman H; Krenkel S; Streichert T; Schweizer M; Riethdorf S; Assmann V; Ihnen M; Beck K; Issa R; Jänicke F; Pantel K; Milde-Langosch K
Breast Cancer Res Treat; 2011 Sep; 129(2):347-60. PubMed ID: 20972617
[TBL] [Abstract][Full Text] [Related]
5. Activated leukocyte cell adhesion molecule (ALCAM) is a marker of recurrence and promotes cell migration, invasion, and metastasis in early-stage endometrioid endometrial cancer.
Devis L; Moiola CP; Masia N; Martinez-Garcia E; Santacana M; Stirbat TV; Brochard-Wyart F; García Á; Alameda F; Cabrera S; Palacios J; Moreno-Bueno G; Abal M; Thomas W; Dufour S; Matias-Guiu X; Santamaria A; Reventos J; Gil-Moreno A; Colas E
J Pathol; 2017 Mar; 241(4):475-487. PubMed ID: 27873306
[TBL] [Abstract][Full Text] [Related]
6. MiR-148a and miR-152 reduce tamoxifen resistance in ER+ breast cancer via downregulating ALCAM.
Chen MJ; Cheng YM; Chen CC; Chen YC; Shen CJ
Biochem Biophys Res Commun; 2017 Feb; 483(2):840-846. PubMed ID: 28063929
[TBL] [Abstract][Full Text] [Related]
7. ALCAM, activated leukocyte cell adhesion molecule, influences the aggressive nature of breast cancer cells, a potential connection to bone metastasis.
Davies S; Jiang WG
Anticancer Res; 2010 Apr; 30(4):1163-8. PubMed ID: 20530423
[TBL] [Abstract][Full Text] [Related]
8. ALCAM/CD166 is a TGF-β-responsive marker and functional regulator of prostate cancer metastasis to bone.
Hansen AG; Arnold SA; Jiang M; Palmer TD; Ketova T; Merkel A; Pickup M; Samaras S; Shyr Y; Moses HL; Hayward SW; Sterling JA; Zijlstra A
Cancer Res; 2014 Mar; 74(5):1404-15. PubMed ID: 24385212
[TBL] [Abstract][Full Text] [Related]
9. Novel role for ALCAM in lymphatic network formation and function.
Iolyeva M; Karaman S; Willrodt AH; Weingartner S; Vigl B; Halin C
FASEB J; 2013 Mar; 27(3):978-90. PubMed ID: 23169771
[TBL] [Abstract][Full Text] [Related]
10. Endophilin-A3 and Galectin-8 control the clathrin-independent endocytosis of CD166.
Renard HF; Tyckaert F; Lo Giudice C; Hirsch T; Valades-Cruz CA; Lemaigre C; Shafaq-Zadah M; Wunder C; Wattiez R; Johannes L; van der Bruggen P; Alsteens D; Morsomme P
Nat Commun; 2020 Mar; 11(1):1457. PubMed ID: 32193381
[TBL] [Abstract][Full Text] [Related]
11. Activated leukocyte cell adhesion molecule expression is up-regulated in the development of endometrioid carcinoma.
Liang S; Huang C; Jia S; Wang B
Int J Gynecol Cancer; 2011 Apr; 21(3):523-8. PubMed ID: 21430457
[TBL] [Abstract][Full Text] [Related]
12. Prognostic Significance of Activated Leukocyte Cell Adhesion Molecule (ALCAM) in Association with Promoter Methylation of the ALCAM Gene in Breast Cancer.
Jeong YJ; Oh HK; Park SH; Bong JG
Molecules; 2018 Jan; 23(1):. PubMed ID: 29315254
[TBL] [Abstract][Full Text] [Related]
13. Enhanced down-regulation of ALCAM/CD166 in African-American Breast Cancer.
Tan F; Mosunjac M; Adams AL; Adade B; Taye O; Hu Y; Rizzo M; Ofori-Acquah SF
BMC Cancer; 2014 Sep; 14():715. PubMed ID: 25255861
[TBL] [Abstract][Full Text] [Related]
14. Syntenin-1 and ezrin proteins link activated leukocyte cell adhesion molecule to the actin cytoskeleton.
Tudor C; te Riet J; Eich C; Harkes R; Smisdom N; Bouhuijzen Wenger J; Ameloot M; Holt M; Kanger JS; Figdor CG; Cambi A; Subramaniam V
J Biol Chem; 2014 May; 289(19):13445-60. PubMed ID: 24662291
[TBL] [Abstract][Full Text] [Related]
15. Activated leukocyte cell adhesion molecule expression correlates with the WNT subgroup in medulloblastoma and is involved in regulating tumor cell proliferation and invasion.
Achiha T; Kijima N; Kodama Y; Kagawa N; Kinoshita M; Fujimoto Y; Nonaka M; Fukai J; Inoue A; Nishida N; Yamanaka T; Harada A; Mori K; Tsuyuguchi N; Uda T; Ishibashi K; Tomogane Y; Sakamoto D; Shofuda T; Yoshioka E; Kanematsu D; Mano M; Luu B; Taylor MD; Kanemura Y; Kishima H
PLoS One; 2020; 15(12):e0243272. PubMed ID: 33270750
[TBL] [Abstract][Full Text] [Related]
16. ALCAM Mediates DC Migration Through Afferent Lymphatics and Promotes Allospecific Immune Reactions.
Willrodt AH; Salabarria AC; Schineis P; Ignatova D; Hunter MC; Vranova M; Golding-Ochsenbein AM; Sigmund E; Romagna A; Strassberger V; Fabbi M; Ferrini S; Cursiefen C; Neri D; Guenova E; Bock F; Halin C
Front Immunol; 2019; 10():759. PubMed ID: 31031759
[TBL] [Abstract][Full Text] [Related]
17. Human T-Lymphotropic Virus Type 1-Induced Overexpression of Activated Leukocyte Cell Adhesion Molecule (ALCAM) Facilitates Trafficking of Infected Lymphocytes through the Blood-Brain Barrier.
Curis C; Percher F; Jeannin P; Montange T; Chevalier SA; Seilhean D; Cartier L; Couraud PO; Gout O; Gessain A; Ceccaldi PE; Afonso PV
J Virol; 2016 Aug; 90(16):7303-7312. PubMed ID: 27252538
[TBL] [Abstract][Full Text] [Related]
18. Dual in vitro invasion/migration suppressing and tamoxifen response modulating effects of a recombinant anti-ALCAM scFv on breast cancer cells.
Darvishi B; Salehi M; Boroumandieh S; Majidzadeh-A K; Jalili N; Moradi-Kalbolandi S; Farahmand L
Cell Biochem Funct; 2020 Jul; 38(5):651-659. PubMed ID: 32196701
[TBL] [Abstract][Full Text] [Related]
19. Modulation of CD6 function through interaction with Galectin-1 and -3.
Escoda-Ferran C; Carrasco E; Caballero-Baños M; Miró-Julià C; Martínez-Florensa M; Consuegra-Fernández M; Martínez VG; Liu FT; Lozano F
FEBS Lett; 2014 Aug; 588(17):2805-13. PubMed ID: 24945728
[TBL] [Abstract][Full Text] [Related]
20. Activated leukocyte cell adhesion molecule (ALCAM/CD166/MEMD), a novel actor in invasive growth, controls matrix metalloproteinase activity.
Lunter PC; van Kilsdonk JW; van Beek H; Cornelissen IM; Bergers M; Willems PH; van Muijen GN; Swart GW
Cancer Res; 2005 Oct; 65(19):8801-8. PubMed ID: 16204050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
